Translating genetic and preclinical findings into autism therapies

Maria Chahrour, Robin J. Kleiman, M. Chiara Manzini

Research output: Contribution to journalArticle

Abstract

Autism spectrum disorder (ASD) is a complex neurodevelopmental disorder characterized by social deficits and repetitive/restrictive interests. ASD is associated with multiple comorbidities, including intellectual disability, anxiety, and epilepsy. Evidence that ASD is highly heritable has spurred major efforts to unravel its genetics, revealing possible contributions from hundreds of genes through rare and common variation and through copy-number changes. In this perspective, we provide an overview of the current state of ASD genetics and of how genetic research has spurred the development of in vivo and in vitro models using animals and patient cells to evaluate the impact of genetic mutations on cellular function leading to disease. Efforts to translate these findings into successful therapies have yet to bear fruit. We discuss how the valuable insight into the disorder provided by these new models can be used to better understand ASD and develop future clinical trials.

Original languageEnglish (US)
Pages (from-to)335-343
Number of pages9
JournalDialogues in Clinical Neuroscience
Volume19
Issue number4
StatePublished - Dec 1 2017

Fingerprint

Autistic Disorder
Therapeutics
Genetic Research
Intellectual Disability
Comorbidity
Epilepsy
Fruit
Anxiety
Animal Models
Autism Spectrum Disorder
Clinical Trials
Mutation
Genes

Keywords

  • Autism spectrum disorder
  • Genetics
  • Genomics
  • Neurodevelopmental disorder
  • Therapy

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry

Cite this

Translating genetic and preclinical findings into autism therapies. / Chahrour, Maria; Kleiman, Robin J.; Manzini, M. Chiara.

In: Dialogues in Clinical Neuroscience, Vol. 19, No. 4, 01.12.2017, p. 335-343.

Research output: Contribution to journalArticle

Chahrour, Maria ; Kleiman, Robin J. ; Manzini, M. Chiara. / Translating genetic and preclinical findings into autism therapies. In: Dialogues in Clinical Neuroscience. 2017 ; Vol. 19, No. 4. pp. 335-343.
@article{98947c48cf0a42569084b0c4fede92ea,
title = "Translating genetic and preclinical findings into autism therapies",
abstract = "Autism spectrum disorder (ASD) is a complex neurodevelopmental disorder characterized by social deficits and repetitive/restrictive interests. ASD is associated with multiple comorbidities, including intellectual disability, anxiety, and epilepsy. Evidence that ASD is highly heritable has spurred major efforts to unravel its genetics, revealing possible contributions from hundreds of genes through rare and common variation and through copy-number changes. In this perspective, we provide an overview of the current state of ASD genetics and of how genetic research has spurred the development of in vivo and in vitro models using animals and patient cells to evaluate the impact of genetic mutations on cellular function leading to disease. Efforts to translate these findings into successful therapies have yet to bear fruit. We discuss how the valuable insight into the disorder provided by these new models can be used to better understand ASD and develop future clinical trials.",
keywords = "Autism spectrum disorder, Genetics, Genomics, Neurodevelopmental disorder, Therapy",
author = "Maria Chahrour and Kleiman, {Robin J.} and Manzini, {M. Chiara}",
year = "2017",
month = "12",
day = "1",
language = "English (US)",
volume = "19",
pages = "335--343",
journal = "Dialogues in Clinical Neuroscience",
issn = "1294-8322",
publisher = "Servier International",
number = "4",

}

TY - JOUR

T1 - Translating genetic and preclinical findings into autism therapies

AU - Chahrour, Maria

AU - Kleiman, Robin J.

AU - Manzini, M. Chiara

PY - 2017/12/1

Y1 - 2017/12/1

N2 - Autism spectrum disorder (ASD) is a complex neurodevelopmental disorder characterized by social deficits and repetitive/restrictive interests. ASD is associated with multiple comorbidities, including intellectual disability, anxiety, and epilepsy. Evidence that ASD is highly heritable has spurred major efforts to unravel its genetics, revealing possible contributions from hundreds of genes through rare and common variation and through copy-number changes. In this perspective, we provide an overview of the current state of ASD genetics and of how genetic research has spurred the development of in vivo and in vitro models using animals and patient cells to evaluate the impact of genetic mutations on cellular function leading to disease. Efforts to translate these findings into successful therapies have yet to bear fruit. We discuss how the valuable insight into the disorder provided by these new models can be used to better understand ASD and develop future clinical trials.

AB - Autism spectrum disorder (ASD) is a complex neurodevelopmental disorder characterized by social deficits and repetitive/restrictive interests. ASD is associated with multiple comorbidities, including intellectual disability, anxiety, and epilepsy. Evidence that ASD is highly heritable has spurred major efforts to unravel its genetics, revealing possible contributions from hundreds of genes through rare and common variation and through copy-number changes. In this perspective, we provide an overview of the current state of ASD genetics and of how genetic research has spurred the development of in vivo and in vitro models using animals and patient cells to evaluate the impact of genetic mutations on cellular function leading to disease. Efforts to translate these findings into successful therapies have yet to bear fruit. We discuss how the valuable insight into the disorder provided by these new models can be used to better understand ASD and develop future clinical trials.

KW - Autism spectrum disorder

KW - Genetics

KW - Genomics

KW - Neurodevelopmental disorder

KW - Therapy

UR - http://www.scopus.com/inward/record.url?scp=85041476987&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041476987&partnerID=8YFLogxK

M3 - Article

VL - 19

SP - 335

EP - 343

JO - Dialogues in Clinical Neuroscience

JF - Dialogues in Clinical Neuroscience

SN - 1294-8322

IS - 4

ER -